Overview

Single Ascending Dose PK, Oral Bioavailability and Food Effect Study in Healthy Male Volunteers

Status:
Completed
Trial end date:
2018-08-14
Target enrollment:
Participant gender:
Summary
This 2-part study will assess the effect of formulation and food on the pharmacokinetics of Indoximod in healthy volunteers. Part 1 is a randomized single ascending dose study of indoximod salt formulation to characterize the PK profile and determine the safety and tolerability of each dose in healthy male volunteers. Part 2 is an open-label, randomized, 3-period, 3-way crossover study. Participants will receive single doses of Indoximod base or salt formulation, in the fasted or fed state.
Phase:
Early Phase 1
Details
Lead Sponsor:
NewLink Genetics Corporation
Treatments:
Tryptophan